Cyclin D 2 rescues size and function of GATA4 haplo-insufficient hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 8, 2012, Pages

  Yamak, Abir ^a   Temsah, Rana ^b   Maharsy, Wael ^a   Caron, Sophie ^b   Paradis, Pierre ^b   Aries, Anne ^b   Nemer, Mona ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Apoptosis; Cardiomyocyte proliferation; Hypertrophy; Transgenic mice

Indexed keywords

CYCLIN D2; TRANSCRIPTION FACTOR GATA 4; CCND2 PROTEIN, MOUSE; CD2 ANTIGEN; GATA4 PROTEIN, MOUSE; GATA4 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HAPLOINSUFFICIENCY; HEART FUNCTION; HEART MUSCLE CELL; HEART SIZE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; APOPTOSIS; CARDIOMEGALY; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRAIN HEK293; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HAPLOTYPE; HEART; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD2; APOPTOSIS; CARDIOMEGALY; CELL PROLIFERATION; CYCLIN D2; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HAPLOTYPES; HEART; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; NIH 3T3 CELLS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 84867724089     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00250.2012     Document Type: Article

References (34)

1. Angelis E, Garcia A, Chan SS, Schenke-Layland K, Ren S, Goodfel-low SJ, Jordan MC, Roos KP, White RJ, MacLellan WR. A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium. Circ Res 102: 1222-1229, 2008.
2. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci USA 101: 6975-6980, 2004.
3. Brooks AR, Shiffman D, Chan CS, Brooks EE, Milner PG. Functional analysis of the human cyclin D2 and cyclin D3 promoters. J Biol Chem 271: 9090-9099, 1996.
4. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S, Nemer M. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 15: 2702-2719, 2001.
5. Debrus S, Rahbani L, Marttila M, Delorme B, Paradis P, Nemer M. The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling. Mol Cell Biol 25: 8669-8682, 2005.
6. Durocher D, Charron F, Warren R, Schwartz RJ, Nemer M. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16: 5687-5696, 1997.
7. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19: 1175-1187, 2005.
8. Georges R, Nemer G, Morin M, Lefebvre C, Nemer M. Distinct expression and function of alternatively spliced Tbx5 isoforms in cell growth and differentiation. Mol Cell Biol 28: 4052-4067, 2008.
9. Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Riviere AB, Doevendans PA, Field LJ. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardio-vasc Res 78: 18-25, 2008.
10. Heineke J, Auger-Messier M, Xu J, Oka T, Sargent MA, York A, Klevitsky R, Vaikunth S, Duncan SA, Aronow BJ, Robbins J, Crombleholme TM, Molkentin JD. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 117: 3198-3210, 2007.
11. Jopling C, Sleep E, Raya M, Marti M, Raya A, Belmonte JC. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464: 606-609, 2010.
12. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342, 1993.
13. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Eg-naczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 464: 601-605, 2010.
14. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477-491, 2004.
15. Kozar K, Sicinski P. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4: 388-391, 2005.
16. Lavallee G, Andelfinger G, Nadeau M, Lefebvre C, Nemer G, Horb ME, Nemer M. The Kruppel-like transcription factor KLF13 is a novel regulator of heart development. EMBO J 25: 5201-5213, 2006.
17. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253, 2001.
18. MacLellan WR, Garcia A, Oh H, Frenkel P, Jordan MC, Roos KP, Schneider MD. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 25: 2486-2497, 2005.
19. Mercola M, Ruiz-Lozano P, Schneider MD. Cardiac muscle regeneration: lessons from development. Genes Dev 25: 299-309, 2011.
20. Nemer G, Nemer M. GATA4 in Heart Development and Disease. In: Heart Development and Regeneration, edited by Rosenthal N and Harvey RP. San Diego, Academic Press, 2010, p. 599-616.
21. Nemer M. Genetic insights into normal and abnormal heart development. Cardiovasc Pathol 17: 48-54, 2008.
22. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98: 837-845, 2006.
23. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M. Over-expression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA 97: 931-936, 2000.
24. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96: 110-118, 2005.
25. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science 331: 1078-1080, 2011.
26. Pu WT, Ishiwata T, Juraszek AL, Ma Q, Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275: 235-244, 2004.
27. Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol 28: 5420-5431, 2008.
28. Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68: 29-49, 2006.
29. Rysa J, Tenhunen O, Serpi R, Soini Y, Nemer M, Leskinen H, Ruskoaho H. GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail 3: 440-450, 2010.
30. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711, 2004.
31. Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda MA. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res 92: e12-e19, 2003.
32. Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H, Nemer M. Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 25: 9829-9844, 2005.
33. Xiong Y, Menninger J, Beach D, Ward DC. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13: 575-584, 1992.
34. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S, Pu WT. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 115: 1522-1531, 2005.